Thus, serum PLIN2 may reflect not only hepatic lipid burden but also a specific failure in lipid clearance, reinforcing its potential as a biomarker of metabolic dysregulation in NAFLD. Here, PLIN2 is linked to metabolic dysfunction-associated steatotic liver disease.